Pricing Log in Create free account
Friday 6 November 2026 Export PRGO’s income statement to Excel — free account

Perrigo Company plc

PRGO Healthcare Drug Manufacturers Specialty & Generic

Perrigo Company plc’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 2.75% from fiscal 2024.

Revenue
−5.24%
EPS
−494.6%
Free cash flow
+138.5%
Total debt
−9.62%

Quarter to September 2026, against a year earlier

15.71 0.00 0.00%
Market cap
$2.2B
P/E
0.0×
Fwd P/E
−7.2×
Dividend yield
7.41%
F-score
4/9
Altman Z
−0.08
Beneish M
−3.51
Dividend safety
16/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Perrigo Company plc (PRGO) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Perrigo Company plc (PRGO) trades at a P/B ratio of 0.9×. Over the past ten years it has ranged from 0.4× (November 2025) to 3.0× (April 2015); the current reading is higher than 24% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 1.8× and below the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 0.7× (19.69%)
FY2024 0.8× (13.12%)
FY2023 0.9× (3.75%)
FY2022 1.0× (3.05%)
FY2021 1.0× (6.27%)
FY2020 1.1× (11.09%)
FY2019 1.2× 28.49%
FY2018 0.9× (54.45%)
FY2017 2.1× (0.59%)
FY2016 2.1× (0.19%)

Quarterly newest first

Period P/B ratio Change
Sep 2026 0.8× 46.75%
Jun 2026 0.6× (3.62%)
Mar 2026 0.6× (9.24%)
Dec 2025 0.7× (5.32%)
43 more quarters

Against its own ten years

Low 0.4× High 3.0×
Ten-year median 1.1×
Current reading's percentile 26

P/B ratio against peers

Company P/B ratio
BCRX BioCryst Pharmaceuticals, Inc. compare n/m
ALVO Alvotech compare n/m
RGC Regencell Bioscience Holdings Limited compare n/m
HCM HUTCHMED (China) Limited Sponsored ADR compare n/m
PRGO Perrigo Company plc 0.9×
PBH Prestige Consumer Healthcare Inc. compare 1.1×
ANIP ANI Pharmaceuticals, Inc. compare 2.3×
TRLV Trulieve Cannabis Corp. compare 2.8×
XERS Xeris Biopharma Holdings, Inc. compare 48.0×
Drug Manufacturers Specialty & Generic industry median 1.8×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on PRGO